Pseudoxanthoma elasticum (PE) is a rare connective tissue disorder characterized by pathological changes in the elastic fiber of the dermis and other manifestations that mainly affect the skin and, less commonly, internal organs. The disease causes degeneration of the elastic fibers, resulting in the formation of icteric papules and plaques on the skin, as well as thickening and loss of tissue elasticity. These changes may be accompanied by systemic disorders, especially in the vascular system, which in turn complicates diagnosis and the choice of effective treatment. Pseudoxanthoma elasticum is often associated with various comorbidities, such as Marfan syndrome, which emphasizes the importance of a comprehensive approach to the examination and treatment of patients.
History of the disease and interesting historical facts
Pseudoxanthoma elasticum was first described in the literature in the early 20th century. The main clinical manifestations of the disease were detailed in the works of such researchers as J. de Bilt and RTT Veras. In the 1970s, it was established that this disease is associated with acid hyaluronidase deficiency, which further enhanced the understanding of the pathogenesis of PE. An interesting fact is that the order of incidence in patients with pseudoxanthoma elasticum largely coincides with genetic studies, which show a relative prevalence of the disease among women compared to men. Studies conducted in recent decades have opened new horizons in understanding the molecular mechanisms of pseudoxanthoma elasticum development, which also emphasizes the importance of a genetic consortium for the study of this rare disease.
Epidemiology
Pseudoxanthoma elasticum is a rare disease, however, even with its low prevalence, epidemiological assessment remains important to understand its impact on the population. According to recent data, the incidence of PE ranges from 1 in 90,000 to 1 in 200,000 people, depending on the region. The vast majority of cases occur in women, especially between the ages of 20 and 40 years. Among the known cases, about 70% observations have associations with other genetic syndromes, such as Marfan syndrome and Ehlers-Danlos syndrome. The importance of epidemiological studies lies not only in assessing the prevalence of the disease, but also in helping to identify associated risks and predisposition to the condition.
Genetic predisposition to this disease
Genetic predisposition to pseudoxanthoma elasticum is largely determined by mutations in specific genes responsible for the synthesis and regulation of collagen and elastin. The most common mutations occur in genes such as ELN, which codes for elastin, and others associated with the synthesis of connective tissues. The causes of mutations can be both hereditary and sporadic. It is important to note that familial cases of pseudoxanthoma elasticum confirm the presence of an autosomal dominant type of inheritance. Various studies have found a high statistical correlation between pseudoxanthoma and other connective tissue diseases, which emphasizes the importance of genetic testing for the diagnosis and prevention of these conditions.
Risk factors for the development of this disease
Certain risk factors may contribute to the development of pseudoxanthoma elasticum. These include:
- Heredity - having a family history of the disease can significantly increase the risk.
- Associated genetic syndromes—such as Marfan syndrome or Ehlers-Danlos syndrome.
- Physical factors such as skin trauma and prolonged exposure to ultraviolet radiation can cause symptoms to progress.
- Chemical factors - exposure to certain chemicals, usually in high concentrations, can also contribute to changes in the structure of connective tissue.
- Infectious agents - some viral infections can modify the immune response, which in turn can affect the course of the disease.
Diagnosis of this disease
The diagnosis of pseudoxanthoma elasticum is based on both clinical data and the results of laboratory and instrumental studies. The main symptoms include:
- The appearance of yellowish or pinkish papules and plaques on the skin, especially in the neck, armpits and soft tissues.
- Thickening of the skin and loss of elasticity.
- Sometimes patients report associated pain or discomfort.
Laboratory studies may include skin biopsy for histologic analysis, which reveals abnormal elastic fibers. Radiologic studies such as ultrasound or MRI may be used to visualize internal structures and rule out associated diseases. Differential diagnosis includes evaluation of other conditions such as xanthelasma, pseudoxanthoma, toxic dermatopathy, and other degenerative skin lesions.
Treatment
Treatment for pseudoxanthoma elasticum is primarily aimed at relieving symptoms and slowing the progression of the disease. Treatment options may include:
- General treatment includes skin care, moisturizers and sunscreens.
- Pharmacological treatment may include the use of corticosteroids to reduce inflammation.
- Surgical treatment may be indicated in the presence of large skin lesions that require removal.
- Physiotherapeutic methods such as laser therapy are also used to improve skin condition and reduce aesthetic defects.
List of medications used to treat this disease
Medications used to treat pseudoxanthoma elasticum include:
- Corticosteroids (eg, prednisone) to reduce inflammation.
- Immunosuppressive drugs (eg, methotrexate) to control active manifestations.
- Topical products containing vitamin E and other moisturizing ingredients.
Disease monitoring
Monitoring of pseudoxanthoma elasticum should be regular and include skin monitoring and assessment of new symptoms. The prognosis of the disease often varies depending on the individual patient and the presence of comorbidities. Potential complications may include improvement or deterioration of the skin condition, development of chronic inflammatory processes, and associated systemic manifestations. It is important to pay attention to possible changes in order to promptly respond to deterioration of health.
Age-related features of the disease
Pseudoxanthoma elasticum can have different manifestations depending on the age of the patient. In children, the disease usually proceeds more aggressively, manifesting as multiple yellowish papules on the skin at an early age, while in adults and the elderly, the disease can begin gradually and manifest itself less clearly. Older people are more likely to have comorbidities such as hypertension or diabetes, which can complicate treatment and lead to more serious consequences.
Questions and Answers
- What is pseudoxanthoma elasticum?
Pseudoxanthoma elasticum is a rare connective tissue disorder that results in degeneration of the elastic fibers that produce the visible changes in the skin. - What are the main symptoms of the disease?
The main symptoms include yellowish or pinkish papules on the skin, loss of elasticity and thickening of the skin. - What are the risk factors associated with the development of pseudoxanthoma elasticum?
Risk factors include heredity, associated genetic syndromes, physical and chemical factors. - How is pseudoxanthoma elasticum diagnosed?
Diagnosis is based on clinical data, histological analysis, laboratory and instrumental studies. - What treatments are used for pseudoxanthoma elasticum?
Treatment includes general skin care, pharmacological treatment, surgical methods and physical therapy.
